Vendevia Group

Gary Reznik, MD.

Managing Partner

 

Dr. Gary Reznik is a Managing Partner of Vendevia Group and provides scientific leadership in the review and oversight of potential and existing investments. Dr. Reznik is focused on leading Academy Clinical Research,  VG’s portfolio company. 

 

Dr. Gary Reznik is a board certified cardiologist and an experienced medical entrepreneur, Dr. Reznik has assembled this practice and created a strong partnership with the Cedars Sinai Medical Center where most of Vita’s surgical interventions take place. He has led a number of clinical trials in cardiology and hypotension studies, holds a number of patents, and has published in the areas of Surgical Cardio Intervention and Invasive Cardiology.

 

Dr. Reznik holds a BS and MS from the University of Michigan and an MD from Wayne State University. He completed his residency at Cedars Sinai Medical Center and Fellowship at the University of California.

Biomedical Venture Development

Boris Reznik, PhD

Chairman

 

Thomas Ichim, PhD

Managing Partner

 

Gary Reznik, MD

Managing Partner

 

Helen Picone, CPA

CFO and Controller

 

Paul Butler, Esq.

Advisory Board

 

Kurt Gehlsen, PhD,

Advisory Board

 

Eugene Golub,

Advisory Board

 

Russel Kaufman, MD,

Advisory Board

 

Robert Pearlman

Advisory Board